JP2023522331A5 - - Google Patents
Info
- Publication number
- JP2023522331A5 JP2023522331A5 JP2022562728A JP2022562728A JP2023522331A5 JP 2023522331 A5 JP2023522331 A5 JP 2023522331A5 JP 2022562728 A JP2022562728 A JP 2022562728A JP 2022562728 A JP2022562728 A JP 2022562728A JP 2023522331 A5 JP2023522331 A5 JP 2023522331A5
- Authority
- JP
- Japan
- Prior art keywords
- solid form
- compound
- xrpd
- theta
- angles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025122305A JP2025142238A (ja) | 2020-04-17 | 2025-07-22 | 血漿カリクレインの阻害剤の形態及び組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063011776P | 2020-04-17 | 2020-04-17 | |
| US63/011,776 | 2020-04-17 | ||
| PCT/US2021/027620 WO2021211930A1 (en) | 2020-04-17 | 2021-04-16 | Forms and compositions of inhibitors of plasma kallikrein |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025122305A Division JP2025142238A (ja) | 2020-04-17 | 2025-07-22 | 血漿カリクレインの阻害剤の形態及び組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023522331A JP2023522331A (ja) | 2023-05-30 |
| JP2023522331A5 true JP2023522331A5 (enExample) | 2024-04-26 |
Family
ID=75870731
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022562728A Pending JP2023522331A (ja) | 2020-04-17 | 2021-04-16 | 血漿カリクレインの阻害剤の形態及び組成物 |
| JP2025122305A Pending JP2025142238A (ja) | 2020-04-17 | 2025-07-22 | 血漿カリクレインの阻害剤の形態及び組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025122305A Pending JP2025142238A (ja) | 2020-04-17 | 2025-07-22 | 血漿カリクレインの阻害剤の形態及び組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230167132A1 (enExample) |
| EP (2) | EP4136091B1 (enExample) |
| JP (2) | JP2023522331A (enExample) |
| DK (1) | DK4136091T3 (enExample) |
| ES (1) | ES3035604T3 (enExample) |
| FI (1) | FI4136091T3 (enExample) |
| PL (1) | PL4136091T3 (enExample) |
| PT (1) | PT4136091T (enExample) |
| WO (1) | WO2021211930A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4494698A3 (en) * | 2017-08-04 | 2025-04-23 | Takeda Pharmaceutical Company Limited | Inhibitors of plasma kallikrein and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6309853B1 (en) | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| JP5069905B2 (ja) * | 2003-01-21 | 2012-11-07 | アプテュイト （ウエスト ラファイエット）、エルエルシー | 新規な共結晶化 |
| WO2011115069A1 (ja) * | 2010-03-19 | 2011-09-22 | 第一三共株式会社 | 結晶の網羅的探索 |
| PT3650439T (pt) * | 2010-07-23 | 2021-03-03 | Gruenenthal Gmbh | Sais ou cocristais de 3-(3-dimetilamino-1-etil-2-metilpropil)fenol |
| EP2663647A4 (en) * | 2011-01-14 | 2015-08-19 | Redwood Bioscience Inc | POLYPEPTIDE IMMUNOGLOBULINS WITH ALDEHYDIC MARKING AND THEIR USE METHOD |
| CN112135825A (zh) * | 2018-03-13 | 2020-12-25 | 夏尔人类遗传性治疗公司 | 血浆激肽释放酶抑制剂及其用途 |
-
2021
- 2021-04-16 EP EP21724430.0A patent/EP4136091B1/en active Active
- 2021-04-16 PL PL21724430.0T patent/PL4136091T3/pl unknown
- 2021-04-16 EP EP25178752.9A patent/EP4623913A3/en active Pending
- 2021-04-16 PT PT217244300T patent/PT4136091T/pt unknown
- 2021-04-16 US US17/919,212 patent/US20230167132A1/en not_active Abandoned
- 2021-04-16 ES ES21724430T patent/ES3035604T3/es active Active
- 2021-04-16 DK DK21724430.0T patent/DK4136091T3/da active
- 2021-04-16 JP JP2022562728A patent/JP2023522331A/ja active Pending
- 2021-04-16 FI FIEP21724430.0T patent/FI4136091T3/fi active
- 2021-04-16 WO PCT/US2021/027620 patent/WO2021211930A1/en not_active Ceased
-
2025
- 2025-07-22 JP JP2025122305A patent/JP2025142238A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11724986B2 (en) | Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use | |
| JP7789850B2 (ja) | Ｌｎｐ０２３の結晶形態 | |
| CN105209437B (zh) | 心肌肌球蛋白激动剂的盐和制备盐的方法 | |
| JP2017505796A5 (enExample) | ||
| CN107427503A (zh) | 2‑(5‑(3‑氟苯基)‑3‑羟基吡啶甲酰胺)乙酸的固体形式、其组合物及用途 | |
| JP2014530805A (ja) | アジルサルタンの結晶形並びにその製造及び使用 | |
| CN110678455B (zh) | 3-苯基-4-丙基-1-(吡啶-2-基)-1h-吡唑-5-醇盐酸盐的新颖结晶型固体化合物 | |
| KR102886764B1 (ko) | Cdk9 억제제의 결정다형 및 이의 제조방법과 용도 | |
| WO2016131431A1 (en) | Solid forms of empagliflozin | |
| JP2019504033A (ja) | 選択的なｓ１ｐ１受容体アゴニストの新規な結晶形及びその製造方法 | |
| CN117736124A (zh) | 萘胺类线粒体自噬诱导剂的固体形式、其制备方法、药物组合物和用途 | |
| TW202602855A (zh) | ４－［３－（環丙基甲氧基）－４－（二氟甲氧基）苯乙基吡啶－２（１ｈ）－酮的固體形式及其製備方法 | |
| KR20200030106A (ko) | 빌란테롤 트리페나테이트의 신규의 결정형 및 이들의 제조방법 | |
| JP2021530526A5 (enExample) | ||
| CN102232070A (zh) | (r)-5-((e)-2-(吡咯烷-3-基乙烯基)嘧啶的合成和新的盐形式 | |
| JP2016512518A (ja) | ベムラフェニブ塩酸塩の固体形態 | |
| US7820716B2 (en) | Crystalline polymorphs of desvenlafaxine succinate and their preparations | |
| TWI765086B (zh) | Parp-1抑制劑的晶型及其製備方法 | |
| TWI666207B (zh) | 一種苯并哌啶類衍生物的鹽、其晶型及鹽、其晶型的製備方法 | |
| CN114075169B (zh) | 奥希替尼药用共晶体及其制备方法 | |
| CN111108098B (zh) | 一种炔基吡啶类脯氨酰羟化酶抑制剂的晶型及其制备方法 | |
| CN120271559A (zh) | 一种吡咯磺酰胺类抑酸剂的盐晶型及其制备方法和应用 | |
| JP2025069143A (ja) | ｔｅｒｔ－ブチル（Ｓ）－２－（（２Ｓ，３Ｒ）－１－アミノ－３－ヒドロキシ－１－オキソブタン－２－イル）－１－オキソ－２，５－ジアザスピロ［３．４］オクタン－５－カルボキシレートの固体形態およびそれらを調製する方法 | |
| JP2018030884A (ja) | テノホビルの固体形態 | |
| KR20220148863A (ko) | 나트륨 2-[(4s)-8-플루오로-2-[4-(3-메톡시페닐)피페라진-1-일]-3-[2-메톡시-5-(트리플루오로메틸)페닐]-4h-퀴나졸린-4-일]아세테이트 3수화물의 결정질 형태를 제조하는 방법 |